236 related articles for article (PubMed ID: 23577214)
1. The cholesterol-dependent cytolysin pneumolysin from Streptococcus pneumoniae binds to lipid raft microdomains in human corneal epithelial cells.
Taylor SD; Sanders ME; Tullos NA; Stray SJ; Norcross EW; McDaniel LS; Marquart ME
PLoS One; 2013; 8(4):e61300. PubMed ID: 23577214
[TBL] [Abstract][Full Text] [Related]
2. Structural insights into loss of function of a pore forming toxin and its role in pneumococcal adaptation to an intracellular lifestyle.
Badgujar DC; Anil A; Green AE; Surve MV; Madhavan S; Beckett A; Prior IA; Godsora BK; Patil SB; More PK; Sarkar SG; Mitchell A; Banerjee R; Phale PS; Mitchell TJ; Neill DR; Bhaumik P; Banerjee A
PLoS Pathog; 2020 Nov; 16(11):e1009016. PubMed ID: 33216805
[TBL] [Abstract][Full Text] [Related]
3. Pneumolysin localizes to the cell wall of Streptococcus pneumoniae.
Price KE; Camilli A
J Bacteriol; 2009 Apr; 191(7):2163-8. PubMed ID: 19168620
[TBL] [Abstract][Full Text] [Related]
4. Novel role for the Streptococcus pneumoniae toxin pneumolysin in the assembly of biofilms.
Shak JR; Ludewick HP; Howery KE; Sakai F; Yi H; Harvey RM; Paton JC; Klugman KP; Vidal JE
mBio; 2013 Sep; 4(5):e00655-13. PubMed ID: 24023386
[TBL] [Abstract][Full Text] [Related]
5. Export requirements of pneumolysin in Streptococcus pneumoniae.
Price KE; Greene NG; Camilli A
J Bacteriol; 2012 Jul; 194(14):3651-60. PubMed ID: 22563048
[TBL] [Abstract][Full Text] [Related]
6. Surface Proteins and Pneumolysin of Encapsulated and Nonencapsulated Streptococcus pneumoniae Mediate Virulence in a Chinchilla Model of Otitis Media.
Keller LE; Bradshaw JL; Pipkins H; McDaniel LS
Front Cell Infect Microbiol; 2016; 6():55. PubMed ID: 27242973
[TBL] [Abstract][Full Text] [Related]
7. Pneumolysin Induces 12-Lipoxygenase-Dependent Neutrophil Migration during
Adams W; Bhowmick R; Bou Ghanem EN; Wade K; Shchepetov M; Weiser JN; McCormick BA; Tweten RK; Leong JM
J Immunol; 2020 Jan; 204(1):101-111. PubMed ID: 31776202
[No Abstract] [Full Text] [Related]
8. Unraveling the Pore-Forming Steps of Pneumolysin from Streptococcus pneumoniae.
van Pee K; Mulvihill E; Müller DJ; Yildiz Ö
Nano Lett; 2016 Dec; 16(12):7915-7924. PubMed ID: 27796097
[TBL] [Abstract][Full Text] [Related]
9. Detoxified pneumolysin derivative Plym2 directly protects against pneumococcal infection via induction of inflammatory cytokines.
Lu J; Sun T; Hou H; Xu M; Gu T; Dong Y; Wang D; Chen P; Wu C; Liang C; Sun S; Jiang C; Kong W; Wu Y
Immunol Invest; 2014; 43(7):717-26. PubMed ID: 25020076
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of Streptococcus pneumoniae pneumolysin provides key insights into early steps of pore formation.
Lawrence SL; Feil SC; Morton CJ; Farrand AJ; Mulhern TD; Gorman MA; Wade KR; Tweten RK; Parker MW
Sci Rep; 2015 Sep; 5():14352. PubMed ID: 26403197
[TBL] [Abstract][Full Text] [Related]
11. Epigallocatechin gallate inhibits Streptococcus pneumoniae virulence by simultaneously targeting pneumolysin and sortase A.
Song M; Teng Z; Li M; Niu X; Wang J; Deng X
J Cell Mol Med; 2017 Oct; 21(10):2586-2598. PubMed ID: 28402019
[TBL] [Abstract][Full Text] [Related]
12. Changes in astrocyte shape induced by sublytic concentrations of the cholesterol-dependent cytolysin pneumolysin still require pore-forming capacity.
Förtsch C; Hupp S; Ma J; Mitchell TJ; Maier E; Benz R; Iliev AI
Toxins (Basel); 2011 Jan; 3(1):43-62. PubMed ID: 22069689
[TBL] [Abstract][Full Text] [Related]
13. Viability and virulence of pneumolysin, pneumococcal surface protein A, and pneumolysin/pneumococcal surface protein A mutants in the ear.
Schachern PA; Tsuprun V; Goetz S; Cureoglu S; Juhn SK; Briles DE; Paparella MM; Ferrieri P
JAMA Otolaryngol Head Neck Surg; 2013 Sep; 139(9):937-43. PubMed ID: 24051749
[TBL] [Abstract][Full Text] [Related]
14. Pneumolysin binds to the mannose receptor C type 1 (MRC-1) leading to anti-inflammatory responses and enhanced pneumococcal survival.
Subramanian K; Neill DR; Malak HA; Spelmink L; Khandaker S; Dalla Libera Marchiori G; Dearing E; Kirby A; Yang M; Achour A; Nilvebrant J; Nygren PÅ; Plant L; Kadioglu A; Henriques-Normark B
Nat Microbiol; 2019 Jan; 4(1):62-70. PubMed ID: 30420782
[TBL] [Abstract][Full Text] [Related]
15. Mapping of Recognition Sites of Monoclonal Antibodies Responsible for the Inhibition of Pneumolysin Functional Activity.
Kucinskaite-Kodze I; Simanavicius M; Dapkunas J; Pleckaityte M; Zvirbliene A
Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32650398
[TBL] [Abstract][Full Text] [Related]
16. Pyruvate oxidase of Streptococcus pneumoniae contributes to pneumolysin release.
Bryant JC; Dabbs RC; Oswalt KL; Brown LR; Rosch JW; Seo KS; Donaldson JR; McDaniel LS; Thornton JA
BMC Microbiol; 2016 Nov; 16(1):271. PubMed ID: 27829373
[TBL] [Abstract][Full Text] [Related]
17. Structure and molecular mechanism of a functional form of pneumolysin: a cholesterol-dependent cytolysin from Streptococcus pneumoniae.
Kelly SJ; Jedrzejas MJ
J Struct Biol; 2000 Oct; 132(1):72-81. PubMed ID: 11121308
[TBL] [Abstract][Full Text] [Related]
18. Protective role of Cav-1 in pneumolysin-induced endothelial barrier dysfunction.
Batori RK; Chen F; Bordan Z; Haigh S; Su Y; Verin AD; Barman SA; Stepp DW; Chakraborty T; Lucas R; Fulton DJR
Front Immunol; 2022; 13():945656. PubMed ID: 35967431
[TBL] [Abstract][Full Text] [Related]
19. The cholesterol-dependent cytolysins pneumolysin and streptolysin O require binding to red blood cell glycans for hemolytic activity.
Shewell LK; Harvey RM; Higgins MA; Day CJ; Hartley-Tassell LE; Chen AY; Gillen CM; James DB; Alonzo F; Torres VJ; Walker MJ; Paton AW; Paton JC; Jennings MP
Proc Natl Acad Sci U S A; 2014 Dec; 111(49):E5312-20. PubMed ID: 25422425
[TBL] [Abstract][Full Text] [Related]
20. Structure-based functional studies for the cellular recognition and cytolytic mechanism of pneumolysin from Streptococcus pneumoniae.
Park SA; Park YS; Bong SM; Lee KS
J Struct Biol; 2016 Feb; 193(2):132-40. PubMed ID: 26688057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]